Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
52.98B
Market cap52.98B
Price-Earnings ratio
54.60
Price-Earnings ratio54.60
Dividend yield
—
Dividend yield—
Average volume
3.28M
Average volume3.28M
High today
$95.34
High today$95.34
Low today
$91.87
Low today$91.87
Open price
$94.42
Open price$94.42
Volume
4.79M
Volume4.79M
52 Week high
$96.29
52 Week high$96.29
52 Week low
$74.66
52 Week low$74.66

Stock Snapshot

Edwards Lifesciences(EW) stock is priced at $92.01, giving the company a market capitalization of 52.98B. It carries a P/E multiple of 54.60.

On 2026-10-31, Edwards Lifesciences(EW) stock moved within a range of $91.87 to $95.34. With shares now at $92.01, the stock is trading +0.2% above its intraday low and -3.5% below the session's peak.

Trading volume for Edwards Lifesciences(EW) stock has reached 4.79M, versus its average volume of 3.28M.

The stock's 52-week range extends from a low of $74.66 to a high of $96.29.

The stock's 52-week range extends from a low of $74.66 to a high of $96.29.

EW News

MarketWatch 23h
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch

...

Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
Simply Wall St 2d
Edwards Lifesciences Could Be 6% Undervalued As FDA Approvals Lift Growth Hopes

Advertisement FDA approvals put Edwards Lifesciences in focus Edwards Lifesciences (EW) is back on investor radars after the FDA cleared its PASCAL Precision...

Simply Wall St 6d
How Valve Device Approvals Will Impact Edwards Lifesciences Stock

Edwards Lifesciences received FDA approval for its PASCAL Precision system for tricuspid valve repair and PASCAL Ace with Capture Clarity for degenerative mitra...

Analyst ratings

75%

of 32 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.